Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12990)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2025 (publication date) through May 1, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Kamrul-Hasan A, Patra S, Dutta D, Nagendra L, Muntahi-Reza A, Borozan S, Pappachan JM. Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis. World J Diabetes 2025; 16(2): 101282 [PMID: 39959269 DOI: 10.4239/wjd.v16.i2.101282] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Kamrul-Hasan A, Patra S, Dutta D, Nagendra L, Muntahi-Reza A, Borozan S, Pappachan JM. Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis. World J Diabetes 2025; 16(2): 101282 [PMID: 39959269 DOI: 10.4239/wjd.v16.i2.101282] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i2/101282.htm |
| Number | Citing Articles |
| 1 |
Deep Dutta, Abul Bashar Mohammad Kamrul-Hasan, Ritin Mohindra, Nishant Raizada. Impact of 1-Year Tirzepatide Use on Glycemic and Metabolic Profile in Overweight to Obese People with Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Technology and Obesity Medicine 2025; 1(1) doi: 10.1089/dtom.2025.0048
|
| 2 |
Arisha Tariq, Adrian Garza Gangemi, Jaime Herrera Caceres. Beyond weight loss: Effect of GLP-1 receptor agonist therapy on the urological health. Urology Case Reports 2026; 65: 103368 doi: 10.1016/j.eucr.2026.103368
|
| 3 |
Lishen Liu, Jingqi Chen, Xiaoming Zhang, Sidong Zhu, Tianfu Dai, Qingping Wu, Yinchao Fang. The relation between tirzepatide and adverse cardiovascular events or renal adverse events: a meta-analysis based on randomized controlled trials. Diabetology & Metabolic Syndrome 2025; 18(1) doi: 10.1186/s13098-025-02064-1
|
| 4 |
Jheng-Yan Wu, Yu-Min Lin, Wan-Hsuan Hsu, Ting-Hui Liu, Ya-Wen Tsai, Po-Yu Huang, Min-Hsiang Chuang, Tsung Yu, Chih-Cheng Lai. Comparative clinical outcomes of adults with obstructive sleep apnea and comorbid obesity receiving tirzepatide versus bariatric metabolic surgery: A Multi-Institutional propensity score matched study. Diabetes Research and Clinical Practice 2025; 226: 112294 doi: 10.1016/j.diabres.2025.112294
|
| 5 |
Guido Gembillo, Luca Visconti, Valeria Tranchida, Chiara Nardi, Sebastiano Calimeri, Maria Elsa Gambuzza, Maria Princiotto, Chiara Chinigo, Luca Soraci, Domenico Santoro. Evolving strategies for nephroprotection in diabetic kidney disease: From established therapies to novel interventions. World Journal of Diabetes 2026; 17(4): 115058 doi: 10.4239/wjd.v17.i4.115058
Abstract(29) |
Core Tip(31) |
Full Article(HTML)(118)
|
Full Article with Cover (PDF)-1633K(206)
|
Audio-564K(3)
|
Peer-Review Report-251K(11)
|
Answering Reviewers-152K(23)
|
Supplementary Material-501K(8)
|
Full Article (PDF)-1376K(111)
|
Full Article (XML)-331K(8)
|
Times Cited (0)
|
Total Visits (1049)
|
Open
|